CIN- L67120MH1995PLC084899


Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Aptus Pharma Ltd.

NSE : BSE : 544529 ISIN CODE : INE15XJ01010Industry : Trading & Distributors

News

  • Aptus Pharma - Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Monday, August 17, 2026 12 Aug 2026 | 17:55 | Dion Global

    Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 inter alia to consider and appr...more...

  • Aptus Pharma - Clarification Letter In Respect Of Outcome Of Board Meeting Held On 08.08.2026 10 Aug 2026 | 14:39 | Dion Global

    Please find attached Clarification letter in respect of Outcome of Board meeting held on 08.08.2026 and submitted on 08.08.2026 for approval...more...
  • Aptus Pharma - Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Preferential Issue Of Shares 08 Aug 2026 | 17:28 | Dion Global

    please find attached outcome of board meeting dated 08.08.2026 for approval of preferential issue of sharesmore...

  • Aptus Pharma - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, August 8, 2026 05 Aug 2026 | 18:43 | Dion Global

    Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 inter alia to consider...more...
  • Aptus Pharma has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026 18 Jul 2026 | 19:20 | Dion Global

    As of June 2026 72.89% is owned by Indian Promoters and 27.11% by Public. Top five Promoters holding highest number of shares of Aptus Pharma company...more...

  • Aptus Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 18 Jul 2026 | 13:15 | Dion Global

    Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018more...
  • Aptus Pharma - Announcement under Regulation 30 (LODR)-Credit Rating 27 Jun 2026 | 13:41 | Dion Global

    Intimation Regarding Credit Rating assigned by CARE Ratings under Reluation 30 of SEBI (LODR) Regulations 2015.more...

  • Aptus Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th June, 2026 12 Jun 2026 | 17:46 | Dion Global

    Outcome of Board Meeting held on 12th June 2026more...
  • Aptus Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation 29 May 2026 | 16:48 | Dion Global

    Announcement Under Regulation 30 (LODR): Investor Presentationmore...

  • Aptus Pharma - Brand Promotion Initiative At Rajkot Hirasar Airport 22 May 2026 | 18:17 | Dion Global

    Intimation under Regulation 30 of SEBI (LODR) Regulations 2015: Brand Promotion Initiative at Rajkot Hirasar Airportmore...
  • Aptus Pharma has submitted to BSE the Shareholding Pattern for the Period Ended May 13, 2026 21 May 2026 | 07:00 | Dion Global

    As of May 2026 72.89% is owned by Indian Promoters and 27.11% by Public. Top five Promoters holding highest number of shares of Aptus Pharma company ...more...

  • Aptus Pharma - Disclosure As Per Regulation 7(2) Of SEBI (PIT) Regulations, 2015 15 May 2026 | 17:12 | Dion Global

    Disclosure as per Regulation 7 (2) of SEBI (PIT) Regulations 2015more...
  • Aptus Pharma - Announcement under Regulation 30 (LODR)-Monitoring Agency Report 06 May 2026 | 20:30 | Dion Global

    Submission of Monitoring Agency Report for the half year ended and year ended on 31st March 2026more...

  • Aptus Pharma - Statement Of Deviation(S) Or Variation(S) In Utilization Of Proceeds Of Initial Public Offer Pursuant To Regul 28 Apr 2026 | 20:10 | Dion Global

    Statement of Deviation(s) or Variation(s) in utilization of proceeds of initial Public Offer pursuant to Regulation 32 of SEBI (Listing Obli...more...
  • Aptus Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release 28 Apr 2026 | 20:06 | Dion Global

    Press release on Financial Results for the Half Year and Year ended on 31st March 2026.more...

  • Aptus Pharma - Intimation Of Record Date For Issue Of Bonus Shares 27 Apr 2026 | 21:01 | Dion Global

    Intimation of Record Date for the Issue of Bonus Sharesmore...
  • Aptus Pharma - Audited Financial Results For The Half Year And Year Ended On 31St March, 2026 27 Apr 2026 | 20:32 | Dion Global

    Audited Financial Results for the half Year and Year ended on 31st March 2026.more...

  • Aptus Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th April, 2026. 27 Apr 2026 | 19:41 | Dion Global

    Outcome of Board Meeting held on 27th April 2026.more...
  • Aptus Pharma - Disclosure Regarding Non-Applicability Of Regulation 24A Of SEBI (Listing Obligations And Disclosure Requireme 25 Apr 2026 | 20:02 | Dion Global

    Disclosure Regarding non-applicability of Regulation 24a of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015more...

  • Aptus Pharma - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 25 Apr 2026 | 19:55 | Dion Global

    Submission of Voting Results and Scrutinizer s Report dated 25th April 2026more...
DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
More
Sensex78009.25-0.09%
NSE Index24366-0.12%
B500DIVL503556.36-0.77%
BSE 1000 11072.45-0.15%
BSE 100LCTMC9218.8-0.10%
BSE Auto 64614.1-0.30%
More

Commodity

Gold151744-0.41%
Silver233500-0.31%
Copper1398.3242.89%
Crude Oil775220.88%
Lead209.8556.14%
Mentha Oil133324.88%
Nickel1619111.11%
More

Currency

USD/INR 95.41(-0.01 %)
GBP/INR 128.62(-0.20 %)
EUR/INR 109.88(-0.17 %)
JPY/INR 0.60(0.23 %)
CAD/INR 68.45(0.00 %)
HKD/INR 12.16(0.00 %)
More


Announcement Calendar

Previous monthAugust 2026Next month
MonTueWedThuFriSatSun
27282930311
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
123456
Upcoming

BOARD MEETINGS
Company Name : Par Drugs & Chem.
Date : 22-08-2026

More

Latest Videos

Watch More Videos